ZUG, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet ...
New, free book offers simple but empowering information on how to care for people with cancer while also caring for yourself. Posted by National Comprehensive Cancer Network Foundation (NCCNF) Today, ...
Tufts in Translation: Predicting Glucose Responses: Building a Virtual Platform for Precision Health
Welcome back to Tufts in Translation where we spotlight faculty advancing new therapeutic approaches, targets, platforms, and delivery systems. Sessions feature early-stage research across the drug ...
Harvard’s Office of Technology Development and LabCentral invite you to the thirdGuppy Tank of 2026, where Harvard life-science innovators will pitch their early-stage concepts to a panel of ...
SeraCare Life Sciences develops, manufactures, and sells a broad range of biological based materials and services essential for the manufacture of diagnostic tests, commercial bioproduction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results